CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briggs, N. C.
Right arrow Articles by Brann, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briggs, N. C.
Right arrow Articles by Brann, E. A.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 401-407, April 2002
© 2002 American Association for Cancer Research

Allergies and Risk of Non-Hodgkin’s Lymphoma by Subtype

Nathaniel C. Briggs1, Robert S. Levine and Edward A. Brann

Division of General Preventive Medicine, Department of Family and Community Medicine, Meharry Medical College, Nashville, Tennessee 37208 [N. C. B., R. S. L.], and Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724 [E. A. B.]

To investigate the relation between allergy and risk for non-Hodgkin’s lymphoma (NHL), data were analyzed from the Selected Cancers Study. Cases (n = 952) were men ages 32–60 years diagnosed with NHL from 1984 to 1988 and identified by eight population-based United States cancer registries. Controls (n = 1691) were recruited by random-digit telephone dialing and frequency matched to cases by age and geographic region of cancer registry. Logistic regression was used to calculate odds ratios and 95% confidence intervals adjusted for age, cancer registry, education, and race/ethnicity. There was no evidence that a general history of allergy was significantly associated with either overall NHL risk (odds ratio: 1.0; 95% confidence interval: 0.8–1.2) or risk for major NHL subtypes (follicular, diffuse, small cell lymphocytic, and immunoblastic). Similarly, no significant associations were observed for the most commonly reported specific allergies, including those to plants, dust, food, animals, and medications. Significant NHL subtype-specific associations were found for allergies to insects (immunoblastic) and chemicals (diffuse and small cell lymphocytic). However, these allergies were reported by relatively few study participants, and the associations may have been because of chance. In conclusion, we found little evidence that either a general history of allergy or commonly reported specific allergies are associated with NHL.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
M. Melbye, K. E. Smedby, T. Lehtinen, K. Rostgaard, B. Glimelius, L. Munksgaard, C. Schollkopf, C. Sundstrom, E. T. Chang, P. Koskela, et al.
Atopy and Risk of Non-Hodgkin Lymphoma
J Natl Cancer Inst, January 17, 2007; 99(2): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. M. Bracci, T. B. Dalvi, and E. A. Holly
Residential history, family characteristics and non-hodgkin lymphoma, a population-based case-control study in the san francisco bay area.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1287 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Gandini, A. B. Lowenfels, E. M. Jaffee, T. D. Armstrong, and P. Maisonneuve
Allergies and the Risk of Pancreatic Cancer: A Meta-analysis with Review of Epidemiology and Biological Mechanisms
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1908 - 1916.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. E. Grulich, C. M. Vajdic, J. M. Kaldor, A. M. Hughes, A. Kricker, L. Fritschi, J. J. Turner, S. Milliken, G. Benke, and B. K. Armstrong
Birth Order, Atopy, and Risk of Non-Hodgkin Lymphoma
J Natl Cancer Inst, April 20, 2005; 97(8): 587 - 594.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. A. Holly and P. M. Bracci
Population-based Study of Non-Hodgkin Lymphoma, Histology, and Medical History among Human Immunodeficiency Virus-negative Participants in San Francisco
Am. J. Epidemiol., August 15, 2003; 158(4): 316 - 327.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.